title: Progress and potential impact of RET kinase targeting in cancer.
authors.affiliation: a Division of Cancer Biology and Genetics, Cancer Research Institute , Queen's University , Kingston , ON , Canada.
authors.forename: Lois M
authors.initials: LM
authors.lastname: Mulligan
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D057285:Precision Medicine; D047428:Protein Kinase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D051096:Proto-Oncogene Proteins c-ret / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D051096:Proto-Oncogene Proteins c-ret; C099282:RET protein, human
keywords: RET; cabozantinib; kinase inhibitor; lung adenocarcinoma; precision oncology; thyroid carcinoma; vandetanib